Current advances in HIV vaccine preclinical studies using Macaque models (Q92019600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

title

Current advances in HIV vaccine preclinical studies using Macaque models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

0 references

Binhua Liang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

Lin Li

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

Yan Hai

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

Ma Luo

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

publication date

11 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

issue

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

3388-3399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

Prevention of HIV-1 infection with early antiretroviral therapy

26 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Progress in HIV vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Lessons learned from human HIV vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Challenges in the development of an HIV-1 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Tackling HIV and AIDS: contributions by non-human primate models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Animal models for HIV/AIDS research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Island biogeography reveals the deep history of SIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Going wild: lessons from naturally occurring T-lymphotropic lentiviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

AIDS as a zoonosis: scientific and public health implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Patterns of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Natural SIV Hosts: Showing AIDS the Door

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

An African primate lentivirus (SIVsm) closely related to HIV-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Divergent CD4 T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Low levels of SIV infection in sooty mangabey central memory CD⁴⁺ T cells are associated with limited CCR5 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

What pediatric nonprogressors and natural SIV hosts teach us about HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Nonhuman primate models for HIV/AIDS vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

AIDS research. Vaccine studies stymied by shortage of animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Hypothetical endogenous SIV-like antigens in Mauritian cynomolgus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Early suppression of SIV replication by CD8 nef-specific cytotoxic T cells in vaccinated macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Mucosal administration of three recombinant Mycobacterium bovis BCG-SIVmac251 strains to cynomolgus macaques induces rectal IgAs and boosts systemic cellular immune responses that are primed by intradermal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Multi-low-dose mucosal simian immunodeficiency virus SIVmac239 challenge of cynomolgus macaques immunized with "hyperattenuated" SIV constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Evaluation of cynomolgus macaque (Macaca fascicularis) endogenous retrovirus expression following simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Rapid development of glycan-specific, broad, and potent anti–HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Genetic and antigenic features of the transmitted virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Early Events in Sexual Transmission of HIV and SIV and Opportunities for Interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Early divergent host responses in SHIVsf162P3 and SIVmac251 infected macaques correlate with control of viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Early antibody therapy can induce long-lasting immunity to SHIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Simian-tropic HIV as a model to study drug resistance against integrase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SHIV susceptibility changes during the menstrual cycle of pigtail macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Relationship of menstrual cycle and vaginal infection in female rhesus macaques challenged with repeated, low doses of SIVmac251.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SIVmac251 Is Inefficiently Transmitted to Rhesus Macaques by Penile Inoculation with a Single SIVenvVariant Found in Ramp-up Phase Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Immune clearance of highly pathogenic SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Rhesus Macaques Vaccinated with , , and Manifest Early Control of SIVmac239 Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Local control of repeated-dose rectal challenges in DNA/MVA-vaccinated macaques protected against a first series of simian immunodeficiency virus challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The role of MHC class I gene products in SIV infection of macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

MHC and KIR Polymorphisms in Rhesus Macaque SIV Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Mhc haplotype M3 is associated with early control of SHIVsbg infection in Mauritian cynomolgus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Novel full-length major histocompatibility complex class I allele discovery and haplotype definition in pig-tailed macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

A 30-year journey of trial and error towards a tolerogenic AIDS vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Progression to AIDS in SIV-Infected Rhesus Macaques is Associated with Distinct KIR and MHC class I Polymorphisms and NK Cell Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Antibody-dependent cellular cytotoxicity in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The role of Fc receptors in HIV infection and vaccine efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

CMV Primes Functional Alternative Signaling in Adaptive Δg NK Cells but Is Subverted by Lentivirus Infection in Rhesus Macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

TRIM E3 ligases interfere with early and late stages of the retroviral life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Fluorescent image analysis of HIV-1 and HIV-2 uncoating kinetics in the presence of old world monkey TRIM5α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Contributions of Mamu-A*01 status and TRIM5 allele expression, but not CCL3L copy number variation, to the control of SIVmac251 replication in Indian-origin rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The TRIM5 gene modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The APOBEC3C crystal structure and the interface for HIV-1 Vif binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Lentivirus restriction by diverse primate APOBEC3A proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Tetherin inhibits HIV-1 release by directly tethering virions to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The ribonuclease activity of SAMHD1 is required for HIV-1 restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Reply to SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Endpoints in vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Analysis of repeated low-dose challenge studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Assessing vaccine effects in repeated low-dose challenge experiments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4( ) T cells are rapidly eliminated in early SIV infection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Highly pathogenic SHIVs and SIVs target different CD4 T cell subsets in rhesus monkeys, explaining their divergent clinical courses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

inferred from DOI database lookup

7 January 2021

based on heuristic

High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

inferred from DOI database lookup

7 January 2021

based on heuristic

CD4 T cells are required to sustain CD8 cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2019.04.094

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2019.04.094

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31088747 AND SRC:MED&resulttype=core&format=json

26 April 2020

1 reference